iSpecimen (ISPC) Change in Accured Expenses (2020 - 2026)
iSpecimen (ISPC) recorded quarterly Change in Accured Expenses of $24261.0 in Q1 2026, up 124.85% quarter-over-quarter from -$97636.0 in Q4 2025, and up 106.92% on a YoY basis from $11724.8 in Q1 2025.
iSpecimen (ISPC) Change in Accured Expenses (2020 - 2026) Analysis & Trends
iSpecimen's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $24261.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 106.92% year-over-year to $24261.0; the TTM figure through Mar 2026 stood at -$174751.0 (up 80.42% YoY), while the FY2025 annual figure was -$549544.0, down 47.8% from the prior year.
- Change in Accured Expenses was $24261.0 for Q1 2026 at iSpecimen, up from -$97636.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $512647.0 in Q4 2023 to a low of -$622926.0 in Q1 2023.
- Historically, Change in Accured Expenses has averaged -$55993.9 across 5 years, with a median of -$16908.0 in 2022.
- Biggest YoY gain for Change in Accured Expenses was 6690.99% in 2023; the steepest drop was 2164.65% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at -$7778.0 in 2022, then soared by 6690.99% to $512647.0 in 2023, then tumbled by 71.44% to $146413.0 in 2024, then tumbled by 166.69% to -$97636.0 in 2025, then jumped by 124.85% to $24261.0 in 2026.
- The last three Change in Accured Expenses figures came in at $24261.0 (Q1 2026), -$97636.0 (Q4 2025), and $71311.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 235.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -322.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 98.23 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -47.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | iSpecimen | 1.02 Mn | -1.79 Mn | -1.39 Mn | 24,261.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,261.00 |
| Mar 31, 2026 | 24,261.00 |
| Dec 31, 2025 | -97,636.00 |
| Dec 31, 2025 | -97,636.00 |
| Sep 30, 2025 | 71,311.00 |
| Sep 30, 2025 | 71,311.00 |
| Jun 30, 2025 | -172,687.00 |
| Jun 30, 2025 | -172,687.00 |
| Mar 31, 2025 | -350,532.00 |
| Mar 31, 2025 | -350,532.00 |
| Dec 31, 2024 | 146,413.00 |
| Dec 31, 2024 | 146,413.00 |
| Sep 30, 2024 | -296,828.00 |
| Sep 30, 2024 | -296,828.00 |
| Jun 30, 2024 | -391,614.00 |
| Jun 30, 2024 | -391,614.00 |
| Mar 31, 2024 | 170,208.00 |
| Mar 31, 2024 | 170,208.00 |
| Dec 31, 2023 | 512,647.00 |
| Dec 31, 2023 | 512,647.00 |